Table 1.
Basic clinical characteristics of the study participants.
| Variable | CSF group (n = 66) | Control group (n = 66) | P value |
|---|---|---|---|
| Male | 30 (45.4) | 35 (46.7) | 0.524 |
| Age (years) | 57.18 ± 9.43 | 55.31 ± 9.82 | 0.387 |
| BMI (kg/m2) | 24.2 ± 2.9 | 23.7 ± 3.3 | 0.536 |
| Hypertension | 22 (33.3) | 26 (39.4) | 0.216 |
| Diabetes mellitus | 12 (18.2) | 14 (21.2) | 0.182 |
| Dyslipidemia | 25 (37.9) | 22 (33.3) | 0.207 |
| Family history of CAD | 13 (19.7) | 12 (18.2) | 0.341 |
| Current smoker | 15 (22.7) | 13 (19.7) | 0.123 |
| Systolic BP (mmHg) | 131.02 ± 15.76 | 133.24 ± 17.13 | 0.432 |
| Diastolic BP (mmHg) | 77.61 ± 11.23 | 78.49 ± 12.47 | 0.533 |
| Treatment received | |||
| Aspirin | 44 (66.7) | 40 (60.6) | 0.217 |
| Clopidogrelsulfate bisulfate | 22 (33.3) | 24 (36.4) | 0.312 |
| Statins | 36 (54.5) | 32 (48.5) | 0.094 |
| ACEIs/ARBs | 18 (27.3) | 16 (24.2) | 0.356 |
| Beta blockers | 20 (30.3) | 23 (34.8) | 0.174 |
| Calcium antagonists | 14 (21.2) | 17 (25.8) | 0.105 |
| Nitrates | 45 (68.2) | 41 (62.1) | 0.192 |
Variables measured with number of patients (percentages in parentheses or mean ± SD). CSF: coronary slow flow; BMI: body mass index; CAD: coronary artery disease; BP: blood pressure; LVEF: left ventricular ejection fraction; ACEIs: angiotensin-converting enzyme inhibitors; ARBs: angiotensin-receptor blockers.